Back to Search Start Over

Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]

Authors :
Selsabil Daboussi
Samia Essebaa
Samira Mhamdi
Chiraz Aichaouia
Ghedira Hela
Aida Ayadi
Moetemri Zied
Author Affiliations :
<relatesTo>1</relatesTo>University of Tunis El Manar, Tunis, Tunisia<br /><relatesTo>2</relatesTo>Pneumology, Military Hospital of Tunis, Tunis, 1008, Tunisia<br /><relatesTo>3</relatesTo>Hematology, Military Hospital of Tunis, Tunis, 1008, Tunisia<br /><relatesTo>4</relatesTo>Pathology, Abderrahmen Mami Hospital,, Ariana, 2080, Tunisia
Source :
F1000Research. 12:337
Publication Year :
2023
Publisher :
London, UK: F1000 Research Limited, 2023.

Abstract

Idiopathic chronic eosinophilic pneumonia (ICEP) is a rare interstitial lung disease of unknown cause. It usually responds well to systemic corticosteroid therapy, but relapses are frequent. We describe two cases of 21- and 27-year-old patients, presenting with dyspnea. The diagnosis of steroid-relapsing and steroid-dependent ICEP was made respectively. Mepolizumab was prescribed to both patients. This treatment resulted in successful long-term disease management with much fewer side effects than a traditional corticosteroid therapy.

Details

ISSN :
20461402
Volume :
12
Database :
F1000Research
Journal :
F1000Research
Notes :
Revised Amendments from Version 2 The changes made did not concern the figures or the list of authors, but were modifications to the text in response to the reviewers' queries. Finally We replaced the inappropriate phrase "It is traditionally diagnosed based on the chronic onset of respiratory symptoms" by It is characterized by chronic respiratory symptoms., , [version 3; peer review: 2 approved]
Publication Type :
Academic Journal
Accession number :
edsfor.10.12688.f1000research.130939.3
Document Type :
case-report
Full Text :
https://doi.org/10.12688/f1000research.130939.3